REG - Dr. Martens PLC - Trading Statement

Dr MartensAnnouncement

14/07/2022 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220714:nRSN3858Sa&default-theme=true

RNS Number : 3858S  Dr. Martens PLC  14 July 2022

14 July 2022

Dr. Martens plc - AGM Trading Update

TRADING IN LINE WITH EXPECTIONS; FULL YEAR GUIDANCE REITERATED

 

Today, Dr. Martens plc will hold its Annual General Meeting at 0930 at Camden
Wharf, 28 Jamestown Road, London, NW1 7BY.

Trading since the start of this financial year is in line with our
expectations and the guidance set out at our year end results announcement for
both the half year and the full year. The early months of our financial year
are typically the smallest period of the year, representing the tail end of
the spring/summer trading period.

In the three-month period, Ecommerce was in line with Q422, retail continued
its strong recovery and our wholesale order book has continued to increase
beyond 85% of the full year level as previously disclosed. We implemented the
AW22 price increases fully from early July and to date have opened ten new
stores. All our third-party factories are open and operating at 90-95% planned
capacity, and shipping lead times continue to improve steadily.

 

Enquiries

Investors and analysts

Mark Blythman, Interim Director of Investor Relations
      +44 7570 871207

mark.blythman@drmartens.com (mailto:mark.blythman@drmartens.com)

Media
 

Gill Hammond, Director of Communications
           +44 7384 214248

Maitland
     +44 20 7379 5151

Clinton Manning                                       +44
7711 972 662

Joanna Davidson                                     +44 7827
254 567

 

Financial calendar

The next scheduled events are:

·      Interim results 24 November 2022

·      Q3 trading update 26 January 2023

·      Full year results 01 June 2023

About Dr. Martens

Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire.
Originally produced for workers looking for tough, durable boots, the brand
was quickly adopted by diverse youth subcultures and associated musical
movements. Dr. Martens has since transcended its working-class roots while
still celebrating its proud heritage and, six decades later, "Docs" or "DMs"
are worn by people around the world who use them as a symbol of empowerment
and their own individual attitude.

 

The Company listed successfully on the main market of the London Stock
Exchange on 29 January 2021 (DOCS.L) and is a constituent of the FTSE 250
index.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  TSTBKNBPNBKDQOD